Application of a validated, stability-indicating LC method to stress degradation studies of ramipril and moexipril.HCl

Chromatographia

Volumn 67, Issue 7-8, 2008, Pages 567-573

  Elshanawane, Abdalla A ^a   Mostafa, Samia M ^b   Elgawish, Mohamed S ^b  

^a Zagazig University   (Egypt)

^b Suez Canal University   (Egypt)

Author keywords

Column liquid chromatography; Moexipril.HCl; Ramipril; Stability indicating

Indexed keywords

MOEXIPRIL; RAMIPRIL;

ARTICLE; COLUMN CHROMATOGRAPHY; DRUG FORMULATION; DRUG STABILITY; DRUG SYNTHESIS; HYDROLYSIS; ISOMERIZATION; PHOTOLYSIS; PRIORITY JOURNAL; REVERSED PHASE LIQUID CHROMATOGRAPHY;

EID: 41849088022     PISSN: 00095893     EISSN: 16121112     Source Type: Journal    
DOI: 10.1365/s10337-008-0544-3     Document Type: Article

References (16)

1. National Heart and Blood Institute National High Blood Pressure Education Program (2003) Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure (JNC VII) express. Bethesda. From the NIH web site
2. Abrams AC (2004) Clinical drug therapy 7th edn. Canadian Pharmaceutical Association, Canada, pp 797-818
3. Sweetman SC (2005) Martindale the complete drug reference 34th edn. Pharmaceutical Press, London, pp 961-994
4. Hammes W, Hammes B, Buechsler U, Paar F, Boekens H (1995) J Chromatogr B 670:81-89
5. Erturk S, Cetin SM, Atmaca S (2003) J Pharm Biomed Anal 33:505-510
6. United States pharmacopeia (2005) 28-NF 23. United States Pharmacopeial Convention, Rockville
7. Eckert HG, Munscher G, Oekonomopulos R, Strecker H, Urbach H, Wissmann H (1985) Arzneim Forsch 35:1251-1256
8. Hajdu P, Schmidt D, Bomm M, Hack L, Keller A (1984) Arzneim Forsch 34:1431-1437
9. Ito M, Kuriki T, Goto J, Nambara T (1990) J Liq Chromatogr 13:991-1000
10. Aboul-Enein HY, Bakr SA (1992) Drug Dev Ind Pharm 18:1013-1022
11. Hogan BL, Williams M, Idiculla A, Veysoglu T, Parente E (2000) J Pharm Biomed Anal 23:637-651
12. Bakshi M, Singh B, Singh A, Singh S (2001) J Pharm Biomed Anal 26:1011-1025
13. Stability testing of new drug substances and products (Q1AR2), ICH harmonised tripartite guideline
14. Hanysova L, Vaclavkova M, Dohnal J (2005) J Pharm Biomed Anal 37:1179-1183
15. Strickley RG, Visor GC, Li-Hwa L, Gu L (1989) Pharm Res 6:971-976
16. Snyder RS, Kirkland JJ, Glajch JL (1997) Practical HPLC method development 2nd edn. Wiley, New York, pp 698-700